- Research Alliance Corp. II
Research Alliance Corp. II
3172 North Rainbow Boulevard
Website
We are a newly organized blank check company incorporated on July 17, 2020 as a Delaware corporation formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We have generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial business combination.
While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business focusing on the healthcare industry, with an emphasis on the biotechnology sector where our management has extensive investment experience.
Offering Team
Deal Managers
- Jefferies
Lawyers
- White and Case LLP
Auditors
- WithumSmith+Brown, P.C
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
Deal Tracker
Investors
Filing
17 Mar, 2021Offer
18 Mar, 2021Look Ahead
Lock Up Expiry
18 Sep, 2021Earning
Nov 1, 2018IPO Terms
| Offer Price | $10.00 |
| Offer Size | 13M |